Halozyme Therapeutics, Inc. earnings per share and revenue

HALO earnings per share for the last quarter are 0.82 USD whereas the estimation was 0.80 USD which accounts for 2.68% surprise. Företagets omsättning för samma period uppgår till 230.04 M USD trots den uppskattade siffran 231.00 M USD. Estimated earnings per share for the next quarter are 0.69 USD, and revenue is expected to reach 199.74 M USD. Also watch annual changes over time to get a bigger picture of HALO earnings per share and revenue dynamics.